» Articles » PMID: 35672451

Enterococcus Faecium and Pediococcus Acidilactici Deteriorate Enterobacteriaceae-induced Depression and Colitis in Mice

Overview
Journal Sci Rep
Specialty Science
Date 2022 Jun 7
PMID 35672451
Authors
Affiliations
Soon will be listed here.
Abstract

Gut dysbiosis is closely associated with the outbreak of inflammatory bowel disease (IBD) and psychiatric disorder. The Enterobacteriaceae population was higher in the feces of patients with inflammatory bowel disease (IBD-F) than in those of healthy control volunteers (HC-F). The Enterococcaceae and Lactobacillaceae populations were higher in the feces of IBD patients with depression (IBD/D-F) vs. the feces of IBD patients without depression (IBD/D-F). Therefore, we examined the effects of Klebsiella oxytoca, Escherichia coli, Cronobacter sakazakii, Enterococcus faecium, and Pediococcus acidolactici overpopulated in IBD/D-F and their byproducts LPS and exopolysaccharide (EPS) on the occurrence of depression and colitis in mice. Oral gavages of Klebsiella oxytoca, Escherichia coli, and Cronobacter sakazakii belonging to Enterobacteriaceae, singly or together, caused dose-dependently colitis and depression-like behaviors in germ-free and specific-pathogen-free mice. Although Enterococcus faecium and Pediococcus acidolactici did not significantly cause colitis and depression-like behaviors, they significantly deteriorated Klebsiella oxytoca- or Escherichia coli-induced colitis, neuroinflammation, and anxiety/depression-like behaviors and increased blood LPS, corticosterone, and IL-6 levels. The EPSs from Enterococcus faecium and Pediococcus acidolactici also worsened Klebsiella oxytoca LPS-induced colitis, neuroinflammation, and depression-like behaviors in mice and increased the translocation of fluorescein isothiocyanate-conjugated LPS into the hippocampus. However, Bifidobacterium longum, which was lower in IBD/D-F vs. IBD/D-F, or its EPS suppressed them. In conclusion, Enterococcus faecium and Pediococcus acidolactici, known as a probiotic strain, and their EPSs may be a risk factor for the outbreak of depression and IBD.

Citing Articles

Lactococcus lactis and Bifidobacterium bifidum alleviate postmenopausal symptoms by suppressing NF-κB signaling and microbiota dysbiosis.

Shin Y, Ma X, Joo M, Baek J, Kim D Sci Rep. 2024; 14(1):31675.

PMID: 39738244 PMC: 11685947. DOI: 10.1038/s41598-024-81500-0.


Impact of the gut microbiota-Th17 cell axis on inflammatory depression.

Jia X, Wang J, Ren D, Zhang K, Zhang H, Jin T Front Psychiatry. 2024; 15:1509191.

PMID: 39655201 PMC: 11625820. DOI: 10.3389/fpsyt.2024.1509191.


The extracellular vesicle of depressive patient-derived Escherichia fergusonii induces vagus nerve-mediated neuroinflammation in mice.

Ma X, Park H, Shin Y, Kim J, Hong J, Han S J Neuroinflammation. 2024; 21(1):224.

PMID: 39277768 PMC: 11402204. DOI: 10.1186/s12974-024-03211-7.


Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases.

Jin D, Morton J, Bonneau R mSystems. 2024; 9(8):e0029524.

PMID: 39078158 PMC: 11334437. DOI: 10.1128/msystems.00295-24.


Dietary Methionine Restriction Improves Gut Health and Alters the Plasma Metabolomic Profile in Rats by Modulating the Composition of the Gut Microbiota.

Yang M, Xie Q, Xiao Y, Xia M, Chen J, Tan B Int J Mol Sci. 2024; 25(7).

PMID: 38612469 PMC: 11011829. DOI: 10.3390/ijms25073657.


References
1.
Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H . Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review. J Psychosom Res. 2016; 87:70-80. DOI: 10.1016/j.jpsychores.2016.06.001. View

2.
Scardaci R, Bietto F, Racine P, Boukerb A, Lesouhaitier O, Feuilloley M . Norepinephrine and Serotonin Can Modulate the Behavior of the Probiotic NCIMB10415 towards the Host: Is a Putative Surface Sensor Involved?. Microorganisms. 2022; 10(3). PMC: 8954575. DOI: 10.3390/microorganisms10030487. View

3.
Graff L, Walker J, Bernstein C . Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009; 15(7):1105-18. DOI: 10.1002/ibd.20873. View

4.
Arboleya S, Watkins C, Stanton C, Ross R . Gut Bifidobacteria Populations in Human Health and Aging. Front Microbiol. 2016; 7:1204. PMC: 4990546. DOI: 10.3389/fmicb.2016.01204. View

5.
Vogelzangs N, de Jonge P, Smit J, Bahn S, Penninx B . Cytokine production capacity in depression and anxiety. Transl Psychiatry. 2016; 6(5):e825. PMC: 5070051. DOI: 10.1038/tp.2016.92. View